dc.creatorJ., Felipe Casas
dc.creatorM., Jaime Camacho
dc.creatorPineda, Ivonne
dc.creatorSandoval, Néstor F.
dc.creatorM., Juan P. Umaña
dc.creatorGuerrero, Albert Franz
dc.creatorObando, Carlos
dc.creatorCabrales, Jaime Ramón
dc.creatorEcheverry, Darío
dc.date.accessioned2020-05-25T23:59:12Z
dc.date.accessioned2022-09-22T15:19:08Z
dc.date.available2020-05-25T23:59:12Z
dc.date.available2022-09-22T15:19:08Z
dc.date.created2020-05-25T23:59:12Z
dc.identifier1205633
dc.identifierhttps://repository.urosario.edu.co/handle/10336/23003
dc.identifierhttps://doi.org/10.1016/j.rccar.2018.06.003
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3446672
dc.description.abstractIntroduction: The endovascular management for diseases of the aorta has increased as an option for patients of high risk for conventional open surgery. The short-term mortality, disease-free and reoperation results, show favourable outcomes compared to open surgery, but there are no results available in this country for the medium (1-12 months) and long-term (>1 year). Methods: A bi-directional cohort study, in which the retrospective segment was conducted on patients subjected to endovascular management with an aortic replacement, and the prospective segment on the follow-up of the patients. Results: A total of 194 patients, subjected to endovascular treatment and met the inclusion criteria, were identified between April 2002 and December 2015. The follow-up was completed in 82.2% of cases. There were 92 (56.8%) cases of abdominal aorta with a mean follow-up of 4.9 years (95% range; 2.5-8.9). The calculated survival was 92% at one year, 86% at 2 years, and 66.4% at 5 years. The period free of disease was 88.7% at one year, 86.4% at 2 years, and 78.5% at 10 years, with 13 patients requiring re-operation. There were 67 cases of thoracic aorta, with a mean follow-up of 5.3 years (95% range; 2.9-10.2). The calculated survival was 94% at one year, 90.7% at 2 years, and 75.2% at 5 years. The period free of disease was 88.7% at one year, 86.4% at 2 years, and 78.5% at 10 years, and 9 patients required re-operation. Conclusions: The results obtained are favourable and are encouraging to continue offering the endovascular approach since the re-operation survival is similar to that reported in the literature. © 2018 Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
dc.languagespa
dc.publisherElsevier B.V.
dc.relationRevista Colombiana de Cardiologia, ISSN:1205633, Vol.26, No.3 (2019); pp. 153-158
dc.relationhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85055648386&doi=10.1016%2fj.rccar.2018.06.003&partnerID=40&md5=3f7cab1d2b906db43e0fec15b3638499
dc.relation158
dc.relationNo. 3
dc.relation153
dc.relationRevista Colombiana de Cardiologia
dc.relationVol. 26
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.titleReoperation-free survival in patients subjected to endovascular treatment of diseases of the aorta
dc.typearticle


Este ítem pertenece a la siguiente institución